These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30711627)

  • 1. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.
    Wan S; Zhao E; Kryczek I; Vatan L; Sadovskaya A; Ludema G; Simeone DM; Zou W; Welling TH
    Gastroenterology; 2014 Dec; 147(6):1393-404. PubMed ID: 25181692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma.
    Zhang L; Li HT; Shereda R; Lu Q; Weisenberger DJ; O'Connell C; Machida K; An W; Lenz HJ; El-Khoueiry A; Jones PA; Liu M; Liang G
    Cancer Lett; 2022 Nov; 548():215899. PubMed ID: 36087682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.
    Chen J; Feng W; Sun M; Huang W; Wang G; Chen X; Yin Y; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Gastroenterology; 2024 Jul; 167(2):264-280. PubMed ID: 38417530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity.
    Yang M; Zhang Z; Chen J; Xu M; Huang J; Wang M; Li W; Wan X; Yuen MF; Luo X; Xi D; Ning Q
    J Exp Clin Cancer Res; 2019 Aug; 38(1):351. PubMed ID: 31409352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1.
    Martínez-López N; García-Rodríguez JL; Varela-Rey M; Gutiérrez V; Fernández-Ramos D; Beraza N; Aransay AM; Schlangen K; Lozano JJ; Aspichueta P; Luka Z; Wagner C; Evert M; Calvisi DF; Lu SC; Mato JM; Martínez-Chantar ML
    Gastroenterology; 2012 Sep; 143(3):787-798.e13. PubMed ID: 22687285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.
    Xie P; Yu M; Zhang B; Yu Q; Zhao Y; Wu M; Jin L; Yan J; Zhou B; Liu S; Li X; Zhou C; Zhu X; Huang C; Xu Y; Xiao Y; Zhou J; Fan J; Hung MC; Ye Q; Guo L; Li H
    J Hepatol; 2024 Jul; 81(1):93-107. PubMed ID: 38403027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy.
    Weng J; Wang Z; Hu Z; Xu W; Sun JL; Wang F; Zhou Q; Liu S; Xu M; Xu M; Gao D; Shen YH; Yi Y; Shi Y; Dong Q; Zhou C; Ren N
    Cancer Res; 2024 Jun; 84(11):1817-1833. PubMed ID: 38484085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA
    Xie Y; Huang Y; Li ZY; Jiang W; Shi NX; Lu Y; Cao G; Yin Z; Lin XJ
    Mol Cancer; 2024 May; 23(1):95. PubMed ID: 38720319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic stress influences the macrophage M1-M2 polarization balance through β-adrenergic signaling in hepatoma mice.
    Yang J; Wei W; Zhang S; Jiang W
    Int Immunopharmacol; 2024 Sep; 138():112568. PubMed ID: 38936055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40 Ligand Linkage.
    Vinh Hanh N; Thi Thanh Thuy L; Ngoc Hieu V; Hai H; Ikenaga H; Sato-Matsubara M; Uchida-Kobayashi S; Urushima H; Van Khanh N; Thi Ha N; Shinkawa H; Kubo S; Ohtani N; Enomoto M; Tamori A; Kawada N
    Am J Pathol; 2024 Jul; 194(7):1230-1247. PubMed ID: 38548267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pumilio RNA binding family member 1 deficiency activates anti-tumor immunity in hepatocellular carcinoma via restraining M2 macrophage polarization.
    Yu Y; Nie G; Ren YW; Ouyang L; Ni CM
    Cell Cycle; 2024 Mar; 23(6):682-692. PubMed ID: 38794797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma.
    Yeung OW; Lo CM; Ling CC; Qi X; Geng W; Li CX; Ng KT; Forbes SJ; Guan XY; Poon RT; Fan ST; Man K
    J Hepatol; 2015 Mar; 62(3):607-16. PubMed ID: 25450711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization.
    Wang M; Li Y; Li S; Wang T; Wang M; Wu H; Zhang M; Luo S; Zhao C; Li Q; Cheng H
    J Ethnopharmacol; 2024 Mar; 321():117472. PubMed ID: 37995825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAMP1 controls CXCL10-CXCR3 axis mediated inflammatory regulation of macrophage polarization during inflammatory stimulation.
    Ye Y; Li L; Kang H; Wan Z; Zhang M; Gang B; Liu J; Liu G; Gu W
    Int Immunopharmacol; 2024 May; 132():111929. PubMed ID: 38555817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma.
    Zhu B; Chen S; Hu X; Jin X; Le Y; Cao L; Yuan Z; Lin Z; Jiang S; Sun L; Yu L
    Neoplasia; 2017 Jul; 19(7):583-593. PubMed ID: 28628795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
    Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
    Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An herbal formula Shenlian decoction upregulates M1/M2 macrophage proportion in hepatocellular carcinoma by suppressing complement cascade.
    Li W; You L; Lin J; Zhang J; Zhou Z; Wang T; Wu Y; Zheng C; Gao Y; Kong X; Sun X
    Biomed Pharmacother; 2024 Aug; 177():116943. PubMed ID: 38878636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD74
    Xiao N; Li K; Zhu X; Xu B; Liu X; Lei M; Sun HC
    Cancer Immunol Immunother; 2022 Jan; 71(1):57-69. PubMed ID: 34009409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.